{"name":"Quoin Pharmaceuticals","slug":"quoin-pharmaceuticals","ticker":"","exchange":"","domain":"quoin.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":9802807,"netIncome":-15804655,"cash":3818096,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNSDRGck9MTzUzSWo4MEY1UlZYLXowRC1laEdaWWVyLWV2U3FYUHRlTm5kSDk1ZG9OSmtfR1JhYlBaTmFFZ1hXZ25aeFVmVEJpUXpUYktrOTRrZ3d5RGQxVjVxQ1VnczRPRGFfYkc1dUgyaVc4emNZdzVseXJRMTR2YkR0aXJVaDBqV1FYZ2JhcUU5WGF3NlNDWnhndkJyczY4ajV5MXE0MzdzRWtONmlub09WSFBWZzFsM1JkMjBR?oc=5","date":"2026-03-26","type":"trial","source":"stocktitan.net","summary":"Quoin lands $104.5M as rare skin drug child study expands - stocktitan.net","headline":"Quoin lands $104.5M as rare skin drug child study expands","sentiment":"neutral"},{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPMWtmWFdxWTViODNwZ2V2aktzVUc0VkRQOXJ0dUFNNGVJMmtGS05nWmtkSnBwUUROZ2tHUFROWUUxZkxrVzk1czN3VDFSMlktRlJDdDJfMDJEaGQ0Qnd1QklIdnNYWlZETWxld1Y2WHhkblRTaTQzc1JINmJBMjVWcG9KRjEtUm0yMU0xVDZsVWxNRnUwcFh0MEhRV2FqM2lHWHk3YU1PeWtVVmgxSFd6Zm5IdUV0aE0?oc=5","date":"2026-03-19","type":"pipeline","source":"stocktitan.net","summary":"Quoin Pharma sets March 26 update with 2025 results before market open - stocktitan.net","headline":"Quoin Pharma sets March 26 update with 2025 results before market open","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPYVNxbDNrMzBFOUxGQU02b1FvckRVc0ZvaEtSc1k4cWxLYUhZeGx6R3k5U3htTnFRYW9kYlFlYTFKRnFzaVBpNTZCT2NaMnNsSkhydjhOOVU0VVVQc3c2STBaYm96SkR5LVJwQ2Zlc2IzWXZRRWZ1dEgtRnlhcHdEZFpPTDRpRVhydVFySGw2NTJrNUhDbmxXUnFta0JTLVpDSEctNF80LXJuRmhvdTNPLVY5YnV5NUptcmszQg?oc=5","date":"2026-03-11","type":"regulatory","source":"stocktitan.net","summary":"FDA Fast Tracks lotion for rare genetic skin disorder with no approved treatment - stocktitan.net","headline":"FDA Fast Tracks lotion for rare genetic skin disorder with no approved treatment","sentiment":"positive"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPdWQwcU4yQlkyYk94cXBLeTJkTG9ZQzJ5Uk5mTUtFVmRHODNaQ2dpbmNTaS16Tnk4cTVYRlR4QU4xVVNlMDdOd21mY3JOaG1pXzh0dDRYbVoyLUtZVU9tNWk5NDZxMmZ1czhlSHR6YnFHRWJzRWUzT2VCc3dMODRHQjJNYVdCQ2QzWHk0ZWtqb0pqZmR5ZkpLTng2dkNmRTQ3ckxJZXk4WHhFYVUwZVpJRmRPUQ?oc=5","date":"2025-10-27","type":"regulatory","source":"Dermatology Times","summary":"ICYMI: Quoin's QRX003 Receives FDA Orphan Drug Status for Netherton Syndrome - Dermatology Times","headline":"ICYMI: Quoin's QRX003 Receives FDA Orphan Drug Status for Netherton Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQZXRMZXhWeE9vaG1iWkV1aWxlTmtFY29RbXVWcW9teEJUMFBvYVVsYmhtazA3ck1Qa3dacXlHbzhxaks0Mkt5WktZU2lnQmNwOVQ2cEhfbThXRldyZVVYRjVJQld1VTByZ1dSeXc5dTNmdF9qa0xncHcxZ3MzalNBR1J6TzdYMGFWMWFzNklBUlhnaFdySEFaQkxqeXluRkhzcFc5UXZKTzVCaTNSU291OEpHVQ?oc=5","date":"2025-10-21","type":"regulatory","source":"stocktitan.net","summary":"Quoin (NASDAQ: QNRX) secures FDA Orphan Drug Designation for QRX003 in Netherton Syndrome - stocktitan.net","headline":"Quoin (NASDAQ: QNRX) secures FDA Orphan Drug Designation for QRX003 in Netherton Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNMFdBS3B5eC0tYndUQjRFS29pTTR3VmJfWjhROTJ4NG4zWWVaY1l3TURSakpoYkd0M3A3OFBzOXMtTXRkbHBFWFhpNmZMazR4dDQ5aUJweVJYYkRVcmhsUWlheVgtY3VwOEZCWko4ZlE4bW9rSERMT3REZ0JFUlZxQ2FVanZmMEJNUWhCOEFJekhLODJJYUVRdVlUQTFGaThyOV9ubGgxdzgtcUNkUWJfMHdkQ3RqU09RaDBuZG1HSEVwcVBrS0NXUU5fRTlfdW5zZGlCQmlLTjB4cFdHTTF3M3JfUDZPSXVEZ2c?oc=5","date":"2025-10-10","type":"pipeline","source":"GlobeNewswire","summary":"Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million - GlobeNewswire","headline":"Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQTzJSMWNWbUl4eWNURDFiRkhkbzZJdHBXX05KUXVNREE0MVJaWS0xTVFUMkFWT2dHaDBTczhrS1o3clB5U0o5bi1kQV9uNzBpTkxodW5pOHh2OUg0VWdhMWhsQVVkZy1YS3p2Z2MxMG9JNC1KSFh3QWpQenJ4S190SDlCWWJ6MjUzbXBiczNpUV9RenQtR2pYX29kYTJodzlSa0NLSk1EaXVVdWFqb3c?oc=5","date":"2025-07-29","type":"pipeline","source":"Fierce Biotech","summary":"Quoin picks its cornerstone, shelving 2 assets to build around lead program - Fierce Biotech","headline":"Quoin picks its cornerstone, shelving 2 assets to build around lead program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQX201U0Y2czk4WEZkaUQ1MUpnaDVPc3pQSHJ0MUs4OHNpTlNEZXlybkdUVmZsWkczeUhxXzRVYkRsNDhJX3NUcE5oZTc2VWVFZ1gtWnZ6Y3V0c0tUTU4tYmx3dXp3US1HOTRJRzZvb21fWDZ3dmlYRm01WVlTdGZtUUp2SUxHcUt5V1VGcEFRUi1vNndyN3MtWg?oc=5","date":"2025-05-22","type":"regulatory","source":"Dermatology Times","summary":"Quoin Receives FDA Clearance for Second Netherton Trial - Dermatology Times","headline":"Quoin Receives FDA Clearance for Second Netherton Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE96T2J3YVR1OGxRZm1NbU9DbUFwSmw3dUxHN1VlNEk1ejRNVGNzbEFaUTU4YWhnWm9ranh0emUwaWhyY1V6U1ZKV2xRbExJTUMtV0E?oc=5","date":"2021-12-08","type":"pipeline","source":"Yahoo Finance UK","summary":"Quoin Pharmaceuticals, Ltd. (QNRX) stock price, news, quote and history - Yahoo Finance UK","headline":"Quoin Pharmaceuticals, Ltd. (QNRX) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1jYnowVkl1TVVYd3FNbEhsb0RuVFRjTmhYVmJidU9uNjNfdl9DZXhDTk9sNTN2VDBXR24zaDdqenlMTGVITkpkR2NoOTVBRzhXb0haSWNja1QwbHRK?oc=5","date":"2021-11-11","type":"pipeline","source":"TradingView","summary":"QNRX Stock Price and Chart — NASDAQ:QNRX - TradingView","headline":"QNRX Stock Price and Chart — NASDAQ:QNRX","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":0,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"},{"value":0,"period":"2019-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":9802807,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-15804655,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":3818096,"cashHistory":[],"totalAssets":20390569,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}